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Oxidative stress is implicated in the pathogenesis and/or maintenance of elevated blood pressure in hypertension. This study
investigated the eﬀect of honey on elevated systolic blood pressure (SBP) in spontaneously hypertensive rats (SHR). It also
evaluated the eﬀect of honey on the amelioration of oxidative stress in the kidney of SHR as a possible mechanism of its
antihypertensive eﬀect. SHR and Wistar Kyoto (WKY) rats were randomly divided into 2 groups and administered distilled water
or honey by oral gavage once daily for 12 weeks. The control SHR had signiﬁcantly higher SBP and renal malondialdehyde (MDA)
levels than did control WKY. The mRNA expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and glutathione S-
transferase (GST) were signiﬁcantly downregulated while total antioxidant status (TAS) and activities of GST and catalase (CAT)
were higher in the kidney of control SHR. Honey supplementation signiﬁcantly reduced SBP and MDA levels in SHR. Honey
signiﬁcantly reduced the activities of GST and CAT while it moderately but insigniﬁcantly upregulated the Nrf2 mRNA expression
level in the kidney of SHR. These results indicate that Nrf2 expression is impaired in the kidney of SHR. Honey supplementation
considerably reduces elevated SBP via amelioration of oxidative stress in the kidney of SHR.
1.Introduction
Cardiovascular disease (CVD) is a main cause of death glob-
ally. The high incidence of CVD is ascribed to the increasing
prevalence of modiﬁable cardiovascular risk factors such as
hypertension, diabetes mellitus, obesity, lipid abnormalities,
smoking, and sedentary lifestyle [1]. Epidemiological studies
indicate that hypertension is a major public health concern
not only because of its high prevalence but also being an
important risk factor for the development of CVD, end-stage
renal disease, stroke, and death [2–4]. Over the past decade,
the role of reactive oxygen species (ROS) and/or reactive
nitrogen species (RNS) in hypertension has been a subject of
much research interest. ROS/RNS play an important role in
the pathogenesis of hypertension [5] and are also associated
with elevated blood pressure [6]. Evidence from literature
suggests that elevated levels of ROS/RNS cause oxidative
stress which is an important mediator in the imbalance
between vasoconstrictor and vasodilator mechanisms in
both experimental and human hypertension [5, 7–9]. In
response to various oxidants, antioxidant enzymes undergo
diﬀerentialregulationormodulation[10–12].Thesechanges2 Oxidative Medicine and Cellular Longevity
usually occur in the form of upregulation or downregulation
of the activities and expressions of antioxidant enzymes; the
mainpurposeistoprotectagainstoxidativedamage[10–12].
These experimental and clinical ﬁndings which implicate
a role of oxidative stress in hypertension have resulted in
a vast interest in therapeutic approaches or interventions
that target oxidative stress in the treatment of hypertension
[13, 14]. Besides its sugar composition, honey consists
of a number of bioactive compounds such as phenolic
compounds, ﬂavonoids, carotenoid-like derivatives, organic
acids, Maillard reaction products, catalase, ascorbic acid,
and other compounds which function as antioxidants [15].
Several therapeutic and medicinal eﬀects such as antibac-
terial, antimutagenic, antiproliferative, hepatoprotective,
hypoglycemic, and antioxidant eﬀects have been ascribed to
honey in recent years [16–21]. In contrast, there are limited
or no available data on the eﬀectiveness or eﬃcacy of honey
supplementation on elevated blood pressure. Recently, we
reported that STZ-induced diabetes mellitus caused reduced
SBP in SHR [12]. This hypotensive eﬀect of diabetes on
elevated blood pressure was also reported by other authors
[22–24]. Besides, our study indicated that short-term (3
weeks) administration of Malaysian tualang honey in STZ-
induced diabetic SHR resulted in further reduction in SBP
[12]. Since honey was not administered to nondiabetic SHR
in that study [12], it is uncertain whether the reduction
in SBP after honey supplementation is due to honey or
secondary eﬀect of diabetes mellitus. Therefore, this study
was carried out to investigate the eﬀect of Malaysian tualang
honeysupplementationonelevatedSBPinnondiabeticSHR.
We also evaluated the eﬀect of this honey on amelioration
of renal oxidative stress as a possible mechanism of its
hypotensive or antihypertensive eﬀect. Malaysian tualang
honey is produced by the wild Asian bee (Apis dorsata).
It gets its name from the tualang tree (Koompassia excelsa)
which houses the hives of the bees. This tree can be found
growing in the Southeast Asian rainforests of peninsular
Malaysia, southern Thailand, northeastern Sumatra, Borneo,
and Palawan.
2. Results
2.1. Eﬀect of Honey on Systolic Blood Pressure in WKY and
SHR. Figure 1 shows the systolic blood pressure (SBP) in
control and honey-treated WKY and SHR. Before treatment,
SBP was signiﬁcantly (P<0.01) higher in the SHR control
than in the WKY control (Figure 1). Over the duration
of treatment, the SBP was markedly (P<0.01 or P<
0.01) higher in SHR while it remained constant in WKY.
In contrast, there was a signiﬁcant (P<0.05 or P<
0.01) suppression of SBP in honey-treated SHR compared to
SHR control. In SHR control, SBP at the end of the study
was signiﬁcantly (P<0.05) higher than SBP before the
commencementofthestudy(Figure 1).SBPwassigniﬁcantly
(P<0.01) lower in the honey-treated SHR than in the SHR
control. Compared with control WKY, the honey-treated
SHRs were still hypertensive. Honey supplementation did
not aﬀect SBP in WKY (Figure 1).
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Figure 1: Eﬀe c to fh o n e yo ns y s t o l i cb l o o dp r e s s u r ei nW K Ya n d
SHR during the treatment period. Each group consisted of six to
seven rats. Data are expressed as mean ± SEM. ∗∗P<0.01 versus
WKY control at the same week; ‡P<0.05,‡‡P<0.01, and ‡‡‡P<
0.001 versus the same group at week 0; §P<0.05 and §§P<0.01
versusthesamegroupatweek 4; †P<0.05and ††P<0.01versus
SHR control at the same week.
0
100
200
300
400
500
600
Week 0 Week 4 Week 8 Week 12
Duration of treatment
B
o
d
y
 
w
e
i
g
h
t
 
(
g
)
∗∗∗∗
‡‡,
§
‡‡,
§§
‡
‡
‡,
§§
‡‡,
§§
‡‡,
§§
WKY control SHR control
WKY honey SHR honey
Figure 2: Eﬀe c to fh o n e yo nb o d yw e i g h ti nW K Ya n dS H Rd u r i n g
thetreatmentperiod.Eachgroupconsistedofsixtosevenrats.Data
are expressed as mean ± SEM. ∗∗P<0.01 versus WKY control at
t h es a m ew e e k ;‡P<0.05 and ‡‡P<0.0 1v e r s u st h es a m eg r o u pa t
week 0; §P<0.05 and §§P<0.01 versus the same group at week 4.
2.2. Eﬀect of Honey on Body Weight in WKY and SHR.
Figure 2 shows the body weight in control and honey-treated
WKY and SHR before and after treatment. Before treatment
commenced, control SHR had signiﬁcantly (P<0.01) lower
body weight compared with control WKY. Over the duration
of treatment, the body weight was markedly (P<0.01
or P<0.01) increased in both WKY and SHR. Similarly,
the body weight increased in WKY and SHR treated with
honey. Supplementation with honey signiﬁcantly (P<0.05)
increased body weight in WKY but not in SHR (Figure 2).
2.3. Eﬀect of Honey on Oxidative Stress Markers in the
Kidney of WKY and SHR. Figure 3 shows the MDA levels
in control and honey-treated WKY and SHR. Control SHR
had signiﬁcantly (P<0.05) higher MDA levels than didOxidative Medicine and Cellular Longevity 3
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Figure 3: Eﬀect of honey on malondialdehyde (MDA) in kidney of
WKY and SHR. Each group consisted of six to seven rats. Data are
expressed as mean ± SEM. ∗P<0.05 versus WKY control; †P<
0.05 versus SHR control.
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Figure 4: Eﬀect of honey on total antioxidant status (TAS) in
kidney of WKY and SHR. Each group consisted of six to seven rats.
Data are expressed as mean ± SEM. ∗P<0.05 versus WKY control.
control WKY. Honey supplementation did not aﬀect MDA
levels of the control WKY group but prevented the increase
inMDAlevelsinSHR.Figure 4showsthe TAS incontroland
honey-treated WKY and SHR. TAS was signiﬁcantly (P<
0.05) higher in control SHR compared with control WKY.
Withhoneytreatment,TASwasreducedbutnotsigniﬁcantly
in SHR. Table 1 shows the levels of reduced glutathione
(GSH), oxidized glutathione (GSSG), and GSH/GSSG ratio
in control and honey-treated WKY and SHR. The levels of
GSH,GSSG,andGSH/GSSGratioweresimilarinthecontrol
and honey-treated WKY and SHR (Table 1).
2.4. Eﬀect of Honey on the Activities of Antioxidant Enzymes in
theKidneyofWKYandSHR. Figure 5showstheCATactivity
in kidney of control and honey-treated WKY and SHR.
ControlSHRhadsigniﬁcantly(P<0.01)higherCATactivity
compared with control WKY. With honey supplementation,
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Figure 5: Eﬀect of honey on catalase (CAT) activity in kidney of
WKY and SHR. Each group consisted of six to seven rats. Data are
expressed as mean ± SEM. ∗∗P<0.01 versus WKY control; ††P<
0.01 versus SHR control. One unit of CAT is deﬁned as the amount
of enzyme that catalyzes the decomposition of 1μmol of H2O2 per
minute.
CAT activity was signiﬁcantly (P<0.01) lower in honey-
supplemented SHR compared with SHR control. Besides,
honey treatment resulted in signiﬁcantly (P<0.01) lower
CAT activity in WKY compared with WKY control. Figure 6
shows the GST activity in kidney of control and honey-
t r e a t e dW K Ya n dS H R .C o n t r o lS H Rh a ds i g n i ﬁ c a n t l y( P<
0.01) higher GST activity compared with control WKY. With
honey treatment, GST activity was signiﬁcantly (P<0.05)
lower in SHR compared with SHR control. Table 1 shows
the activities of superoxide dismutase (SOD), glutathione
peroxidase (GPx), and glutathione reductase (GR) in control
and honey-treated WKY and SHR. Activities of SOD, GPx,
and GR were similar in the all the groups (Table 1).
2.5. Eﬀect of Honey on the mRNA Expressions of Nrf2 and
Antioxidant Enzymes in the Kidney of WKY and SHR.
Figure 7 shows the mRNA expression of Nrf2 in kidney of
control and honey-treated WKY and SHR. Control SHR had
signiﬁcantly (P<0.05) lower mRNA expression of Nrf2
compared with control WKY. The administration of honey
did not produce signiﬁcantly higher mRNA expression of
Nrf2 in SHR compared with SHR control. Figure 8 shows
the mRNA expression of CAT in kidney of control and
honey-treated WKY and SHR. The mRNA expression of
CAT did not diﬀer in control and honey-treated WKY
and SHR. Figure 9 depicts the mRNA expression of GST-
α in kidney of control and honey-treated WKY and SHR.
T h em R N Ae x p r e s s i o no fG S T - α was signiﬁcantly (P<
0.01) downregulated in control SHR compared with control
WKY. Honey supplementation in SHR did not signiﬁcantly
i n c r e a s em R N Ae x p r e s s i o no fG S T - α. Figure 10 shows the
mRNA expression of GST-Π in kidney of control and honey-
treated WKY and SHR. Control SHR exhibited signiﬁcantly
(P<0.01) downregulated mRNA expression of GST-Π4 Oxidative Medicine and Cellular Longevity
Table 1: The activities of antioxidant enzymes and markers of oxidative stress in kidney of WKY control, honey-treated WKY, SHR control,
and honey-treated SHR.
WKY control WKY honey SHR control SHR honey
SOD (U/mg protein) 0.079 ± 0.004 0.071 ± 0.008 0.084 ± 0.006 0.082 ± 0.008
GPx (U/mg protein) 365.2 ± 10.8 356.9 ± 10.0 361.9 ± 6.7 366.0 ± 19.0
GR (U/mg protein) 172.2 ± 4.9 172.9 ± 2.4 177.8 ± 5.5 174.2 ± 8.2
GSH (nmol/mg protein) 0.192 ± 0.020 0.204 ± 0.01 0.219 ± 0.019 0.239 ± 0.033
GSSG (nmol/mg protein) 0.056 ± 0.006 0.064 ± 0.007 0.065 ± 0.006 0.065 ± 0.007
GSH/GSSG 3.46 ± 0.50 3.33 ± 0.31 3.44 ± 0.30 3.53 ± 0.61
Each group consisted of six to seven rats. Data are expressed as mean ± SEM. SOD: superoxide dismutase; GPx: glutathione peroxidase; GR: glutathione
reductase; GSH: reduced glutathione; GSSG: oxidized glutathione. One unit of SOD is deﬁned as the amount of enzyme required to exhibit 50% dismutation
of superoxide radical. One unit of GPx/GR is deﬁned as the amount of enzyme that catalyzes the oxidation of 1nmol of NADPH per minute.
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Figure 6: Eﬀect of honey on glutathione-S-transferase (GST) activ-
ity in kidney of WKY and SHR. Each group consisted of six to seven
rats. Data are expressed as mean ± SEM. ∗∗P<0.01 versus WKY
control; †P<0.05 versus SHR control. One unit of GST is deﬁned
as the amount of enzyme that catalyzes the conjugation of 1nmol
of GSH-CDNB per minute.
compared with control WKY. In WKY, honey supple-
mentation signiﬁcantly (P<0.05) downregulated mRNA
expression of GST-Π. The administration of honey to SHR
did not signiﬁcantly upregulate mRNA expression of GST-
Π. Table 2 shows that the mRNA expressions of CuZnSOD,
MnSOD, and GPx in kidney of control and honey-treated
WKY and SHR did not diﬀer.
3. Discussion
The results indicated that SBP was signiﬁcantly elevated
in control SHR as previously reported [13, 14]. Oxidative
stress is implicated in the pathogenesis and/or maintenance
of elevated blood pressure in hypertension [5–9]. Our data
showed that SBP was signiﬁcantly lower in the honey-treated
SHR compared to control SHR. In contrast, no diﬀerence in
SBP was observed in the honey-treated WKY rats compared
to the control WKY rats. In view of the reported antioxidant
eﬀect of this honey [20, 21], our results are consistent with
published data which demonstrate the beneﬁcial eﬀect of
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Figure 7: Eﬀect of honey on mRNA expression of Nrf2 in the kid-
ney of WKY and SHR. Each group consisted of four to ﬁve rats.
Data are expressed as mean ± SEM. The quantitative fold change
in mRNA expression was determined relative to the β-actin mRNA
levels in each corresponding group and calculated using the 2−ΔΔCT
method. ∗P<0.05 versus WKY control.
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Figure8:EﬀectofhoneyonmRNAexpressionofCATinthekidney
ofWKYandSHR.Eachgroupconsistedoffourtoﬁverats.Dataare
expressed as mean ± SEM. The quantitative fold change in mRNA
expression was determined relative to the β-actin mRNA levels in
eachcorrespondinggroupandcalculatedusingthe2−ΔΔCT method.Oxidative Medicine and Cellular Longevity 5
Table 2: The mRNA expressions of CuZnSOD, MnSOD, and GPx in kidney of WKY control, honey-treated WKY, SHR control, and honey-
treated SHR.
WKY control WKY honey SHR control SHR honey
CuZnSOD 1.00 ± 0.16 0.80 ± 0.10 0.19 ± 0.03 0.26 ± 0.07
MnSOD 1.00 ± 0.06 1.27 ± 0.17 0.74 ± 0.10 1.46 ± 0.33
GPx 1.00 ± 0.14 1.74 ± 0.16 0.53 ± 0.05 0.80 ± 0.10
Each group consisted of four to ﬁve rats. Data are expressed as mean ± SEM. CuZnSOD: copper-zinc superoxide dismutase; GPx: glutathione peroxidase.
The quantitative fold change in mRNA expression was determined relative to the β-actin mRNA levels in each corresponding group and calculated using the
2−ΔΔCT method.
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Figure 9: Eﬀect of honey on mRNA expression of GST-α in kidney
ofWKYandSHR.Eachgroupconsistedoffourtoﬁverats.Dataare
expressed as mean ± SEM. The quantitative fold change in mRNA
expression was determined relative to the β-actin mRNA levels in
each corresponding group and calculated using the 2−ΔΔCT method.
∗∗P<0.01 versus WKY control.
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Figure 10: Eﬀect of honey on mRNA expression of GST-Π in
kidney of WKY and SHR. Each group consisted of four to ﬁve rats.
Data are expressed as mean ± SEM. The quantitative fold change
in mRNA expression was determined relative to the β-actin mRNA
levels in each corresponding group and calculated using the 2−ΔΔCT
method. ∗P<0.05 and ∗∗P<0.01 versus WKY control.
antioxidants on elevated blood pressure in SHR but not in
normotensive WKY rats [13, 14]. In addition to the role of
renaloxidativestressinthepathophysiologyofhypertension,
the causal role of several other factors such as vascular oxida-
tive stress [25], endothelial dysfunction [26], sympathetic
nervous system [27], and renin-angiotensin system [28]i s
wellrecognized. Furthermore,arole ofinsulinresistanceand
other diabetic proﬁle such as enhanced proteolytic activity
and insulin receptor cleavage has been implicated in the
pathogenesis of hypertension in SHR [29, 30]. The fact that
antioxidant (honey) supplementation, despite amelioration
of renal oxidative stress, does not eﬀectively restore SBP
further lends credence to the notion that renal oxidative
stress is not the only cause of elevated blood pressure in SHR
and perhaps in human hypertension.
In many disorders (such as hypertension) associated
with oxidative stress, the main ROS generated is superoxide
anion (O2
•−)[ 5, 7, 8]. O2
•− generates a variety of other
ROS which are of physiological importance [5, 7]. However,
many tissues are endowed with antioxidant enzymes which
play a key role in the detoxiﬁcation of ROS. SOD protects
tissues from oxidative stress and damage by catalyzing the
conversion of O2
•− to H2O2, a more stable ROS [31]. There
was no signiﬁcant change in renal SOD activity of SHR
compared to WKY rats. Although the mRNA expression
of CuZnSOD was slightly lower in the kidney of SHR
compared to WKY rats, no statistically signiﬁcant change in
the mRNA expressions of SOD isoenzymes was observed in
SHR compared to WKY. Similarly, inspite of slightly reduced
mRNA expression of CuZnSOD, no signiﬁcant diﬀerence
in the mRNA expressions of CuZnSOD and MnSOD was
observed in SHR. Our results showed increased CAT activity
in the kidney of control SHR. CAT catalyzes the reduction of
H2O2 to water (H2O) and oxygen (O2). Hence, this enzyme
protects tissues from highly reactive hydroxyl radical (•OH),
derived from H2O2 [32]. In experimental studies, increased
H2O2 concentration is accompanied by elevated activity of
CAT and/or GPx [33, 34]. Therefore, enhanced CAT activity
in the kidney of control SHR may be an adaptive response
to metabolize increased concentrations of H2O2. Although
both CAT and GPx play a major role in the metabolism
of H2O2, GPx is less eﬃcient than CAT because it is easily
inhibited in the presence of increased levels of H2O2 [35, 36].
Considering that elevated H2O2 generation is reported in
SHR [37], enhanced CAT activity in kidney of control SHR
may imply increased H2O2 production and the insuﬃciency
of GPx to detoxify this substrate. Interestingly, the fold6 Oxidative Medicine and Cellular Longevity
change in mRNA expression of CAT in the kidney of SHR
did not diﬀer from that of the WKY rats. Discrepancy in
CAT activity (reduced activity) and CAT mRNA expression
(increased expression) has been reported in brain tissue
of rats [38]. The lack of signiﬁcant change in the activity
and mRNA expression of GPx may further suggest that
GPx compared to CAT plays a less prominent role in
the detoxiﬁcation of elevated levels of H2O2.T r e a t m e n to f
SHR with honey signiﬁcantly reduced CAT activity. This
may be due to reduced bodily demand for an enhanced
endogenous antioxidant defense (CAT) as a result of honey
supplementation. Thus, this conﬁrms that increased CAT
activity in the kidney of SHR is induced in response to
increased oxidative stress.
Our results indicated that concentrations of MDA, a
prominent marker for the assessment of lipid peroxidation
[39, 40], were signiﬁcantly elevated in the kidney of control
SHR. These data corroborate those of other investigators
who reported elevated levels of MDA in the kidney of SHR
[41]. The elevated MDA levels in the kidney of control SHR
indicate increased lipid peroxidation. In our previous study
[12], we reported that the levels of MDA were much lower
in the kidney of SHR than of WKY. We did suggest that the
reduced MDA contents in SHR might be due to increased
CAT activity and enhanced TAS [12]. However, in this study,
we found that the MDA levels were elevated in the kidney
of SHR in spite of enhanced CAT activity and TAS. The
data in the current study suggest that the enhanced CAT
activity and TAS in the kidney of SHR are not protective
against oxidative damage. Honey supplementation in SHR
moderately restored elevated TAS and signiﬁcantly reduced
the levels of MDA, indicative of reduced oxidative damage.
The fact that these honey-treated SHR also had less severe
hypertension is consistent with other studies that reported
increased levels of MDA in hypertension [41, 42].
The data showed an enhanced activity of GST in the
kidney of control SHR. GST protects cells or tissues against
oxidative stress and damage by detoxifying various toxic
substrates, including end products of lipid peroxidation
such as MDA and 4-HNE (4-hydroxynonenal), derived from
cellular oxidative processes [43]. The increased GST activity
may be due to enzyme induction in order to detoxify the
elevatedlevelsofMDAandotherlipidperoxidativeproducts.
This is usually an adaptive or compensatory mechanism
to enhance cellular resistance and protect tissues from the
deleterious eﬀects of these toxic aldehydes [44]. In contrast
to the increased GST activity, the mRNA expressions of
GST-α and GST-Π in the kidney of control SHR were
signiﬁcantly downregulated. Four classes of GST isoenzymes
(GST-α,G S T - μ,G S T - Π,a n dG S T - θ) have been identiﬁed
[45]. Nevertheless, the mRNA expressions of GST-α and
GST-Π were investigated because they are the main GST
isoenzymes predominantly expressed in rat kidney [46]. A
n u m b e ro fc o m p o u n d s ,s u c ha sx e n o b i o t i c s ,l e a da sw e l la s
ROS are reported to induce activity and expressions of GST
isoenzymes [46, 47]. It has been reported that increased GST
activity and upregulated GST-Π expression correlates with
increasedoxidativestressandapoptosisinbreastcancer[48].
The downregulated mRNA expressions of GST-α and GST-
Π in kidney of SHR corroborate those of other authors who
also reported reduced GST mRNA expression in the kidney
of SHR [49]. The administration of honey signiﬁcantly
reduced GST activity in SHR similar to that of normotensive
WKY rats. This may be due to reduced demand for the
induction of renal GST as a result of antioxidant (honey)
supplementation.
The data showed that the mRNA expression of Nrf2 was
signiﬁcantly downregulated in the kidney of SHR compared
to WKY rats, similar to recently reported ﬁndings [50]. Nrf2,
an important transcription factor, detects xenobiotics and
imbalances in redox status and coordinates the transcription
of a variety of cytoprotective genes [51]. Under physiological
conditions, Nrf2 remains bound to Keap1 (Kelch-like ECH-
associating protein 1) in the cytosol [51]. However, under
oxidative or xenobiotic stress, Nrf2 is liberated from its
repressor, Keap1, and translocates from the cytoplasm to
the nucleus [51, 52]. It forms heterodimer with small Maf
(musculoaponeurotic ﬁbrosarcoma) proteins and binds to
the antioxidant response element (ARE) in the promoter
region of a range of detoxifying and cytoprotective genes,
resulting in their transcription [51, 52]. The transcription
of these genes leads to the induction of diﬀerent phase II
metabolizing, free radical scavenging, and other detoxifying
enzymes which swiftly neutralize, detoxify, and eliminate the
oxidantsorxenobiotics[51,52].ThedownregulationofNrf2
mRNA expression paralleled the signiﬁcant downregulation
of mRNA expressions of GST-α and GST-Π in the kidney
of SHR. Besides, the reduced mRNA expression of GST-Π
in honey-treated WKY rats may be due to the downreg-
ulated expression of Nrf2 in these rats. A study reported
that Nrf2-null mice had markedly reduced expression of
several GST isoenzymes [53]. This suggests that the reduced
GST mRNA expressions may be a result of reduced or
impaired expression of Nrf2 in SHR. Our results are also in
agreement with those of Reisman et al. who reported that
the mRNA expressions of cytoprotective genes that detoxify
electrophiles, such as GST, are more inﬂuenced by Nrf2
in keap1-kd mice than those that detoxify reactive oxygen
species, such as SOD, CAT, and GPx [54]. In our previous
study, CAT activity and TAS were increased, but MDA was
reduced in SHR [12]. In this study, in addition to increased
CAT activity and TAS, GST activity was also increased while
the levels of MDA were elevated. Considering the ﬁndings
of Reisman et al. [54], we suggest that there may be a
progression from oxidative stress to electrophilic stress as the
level of oxidative stress increases.
It remains unclear whether reduced mRNA expression
of Nrf2 is a consequence of oxidative stress or otherwise.
Exposure of rat pulmonary microvascular endothelial
cells to low and moderate doses of H2O2 has been shown
to result in the nuclear accumulation of Nrf2, enhanced
Nrf2-ARE-binding activity, and upregulated expression
of ARE-regulated gene [55]. These authors also reported
that, in contrast, cells exposed to H2O2 at high doses
were characterized by H2O2 concentration-dependent
translocation of Nrf2 from the nucleus to the cytosol,
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expression of ARE-mediated gene. The study further
revealed that the levels of cellular damage were considerably
higher in the cells exposed to H2O2 at high doses whereas the
levels of cellular damage in the cells exposed to H2O2 at low
and moderate doses were similar to those under the normal
condition [55]. Similarly, Rojo et al. found that long-term
exposure to H2O2 causes downregulation of Akt, activation
of glycogen synthase kinase-3 beta (GSK-3β), and nuclear
translocation of Nrf2 to the cytoplasm, thereby, impairing
the antioxidant response of cells [56]. By and large, these
ﬁndings corroborate ours in which increased ROS/oxidative
stress and damage in the kidney of SHR was associated with
downregulated expression of Nrf2. These data suggest that
low and moderate doses of H2O2 or perhaps low levels of
oxidative stress may induce Nrf2 activity and expression,
thereby, protecting cellular organelles against oxidative
damage [12, 55]. On the other hand, high concentrations
of H2O2 or elevated levels of ROS/oxidative stress result in
reduced Nrf2 activity and expression, thereby, increasing the
susceptibility of cellular components to oxidative damage
as a result of reduced/impaired antioxidant response of cells
[55, 56]. The signiﬁcantly reduced activity of renal CAT in
honey-treated SHR suggest reduced H2O2 concentrations
as a result of honey supplementation. This may contribute
to increased translocation of Nrf2 from the cytosol to
the nucleus as evidenced by the moderately upregulated
expression of Nrf2 in SHR. Hence, these results indicate that
antioxidants (free radical scavengers), H2O2-metabolizing
enzymes (CAT and/or GPx) as well as other ROS-scavenging
enzymes may elicit a protective eﬀect on Nrf2 and help to
maintain/augment physiological functions of Nrf2.
Moreover, despite increased oxidative stress which is a
key inducer of Nrf2 [50, 51], the kidney of SHR had reduced
Nrf2 mRNA expression. This suggests that Nrf2, a potential
renoprotective transcription factor, may be impaired or
deﬁcient in kidney of SHR, resulting in the inability of SHR
to upregulate Nrf2 in response to oxidative or electrophilic
insult. Honey administration, while moderately though not
signiﬁcantly upregulating Nrf2 mRNA expression, consid-
erably attenuated activities of antioxidant enzymes and
reduced lipid oxidative damage in kidney of SHR similar to
thelevelsinnormotensiveWKYrats.Inviewofthemoderate
upregulation of Nrf2 in honey-treated SHR, one would
have expected similar results in honey-treated WKY rats.
Surprisingly, ourresultsshowedthathoneysupplementation
in normotensive WKY rats was associated with reduced Nrf2
mRNA expressions. The reason remains unclear. However, a
study reported a similar ﬁnding in Keap1-kd mice [54]. The
study showed that Nrf2 mRNA expression was moderately
decreased in Keap1-kd mice compared with wild type. It
is suggested that this may be due to a plausible negative
feedback pathway for Nrf2 mRNA expression as a result of
Nrf2 overactivation [54]. Therefore, the reduction of Nrf2
mRNA expression in kidney of honey-treated WKY rats may
be a consequence of a negative feedback mechanism arising
from increased Nrf2 stimulation and translocation following
daily honey supplementation in WKY rats.
In the kidney of normotensive WKY rats, similar to
our previous studies [20, 57], honey supplementation did
not aﬀect most of the renal oxidative stress parameters
investigated.Surprisingly,ourdatarevealedthatCATactivity
was signiﬁcantly reduced in the honey-supplemented WKY
rats compared to control WKY rats. Besides, we found a
slight trend (but statistically insigniﬁcant) towards reduced
M D Al e v e l si nh o n e y - t r e a t e dW K Yc o m p a r e dw i t hc o n t r o l
WKY rats. These ﬁndings are in contrast with what we found
in our previous studies which showed that the activity of
CAT and the levels of MDA were comparable in the kidney
and pancreas of honey-treated Sprague-Dawley (SD) and
untreated SD rats [20, 57]. These discrepancies may arise
from diﬀerences in rat strains. Similar diﬀerences in markers
of oxidative stress in SD and WKY rats have also been
reported in another study [58]. The reduced CAT activity in
WKYratsmaybeattributedtothedownregulatedexpression
of Nrf2 in these rats [54]. Furthermore, there is evidence
which suggests an association between oxidative stress and
aging process [59], which may provide another possible
explanation for this disparity. In all the studies, the age of the
SDandWKYratsbeforetreatmentcommencedwasthesame
(12–14 weeks old). However, the duration of treatment was
12 weeks in the present study, whereas it was 4 weeks [20, 57]
or 3 weeks [12] in the previous studies. Moreover, renal
production of H2O2 and urinary excretion of MDA has been
reported to be signiﬁcantly higher in older WKY rats than
theiryoungcounterparts[60].Therefore,signiﬁcantlyhigher
CAT activity and slightly higher levels of MDA in the kidney
of control WKY rats compared to honey-treated WKY rats
may imply increased H2O2 generation and the occurrence of
perhaps low levels of oxidative stress in normotensive WKY
rats.
In summary, the increased activity of CAT and TAS
observed in the kidney of SHR in this study and our
previous study [12] may represent an adaptive mechanism
in response to increased oxidative stress. While in the
previous study, this adaptive mechanism appeared to protect
against oxidative damage as evidenced by the signiﬁcantly
reduced levels of MDA in kidney of SHR compared to
WKY rats [12]. In the present study, the enhanced TAS
and CAT activity is not protective against oxidative damage
as evident from the signiﬁcantly elevated levels of MDA
in kidney of control SHR compared to control WKY rats.
The insuﬃciency of adaptive or compensatory mechanism
to protect against oxidative damage may be due to the
longer duration of this study which allowed unrelenting
ROS generation, resulting in increased oxidative stress and
damage. The elevated levels of ROS (perhaps H2O2)a n d
MDA in SHR may result in induction of CAT and GST
activities, respectively. The discrepancies in the results on
the gene expression and activity of the antioxidant enzymes
are in agreement with previously reported ﬁndings which
showed that alterations in mRNA expressions of antioxidant
enzymes do not necessarily correlate with their protein
expressions and/or activities [32, 61–67]. These inconsisten-
cies in the eﬀect of oxidative stress on mRNA expression and
antioxidant enzyme protein/activity are attributed to various
factors including RNA splicing, increased degradation of
the mRNA, protein modiﬁcations such as protein turnover
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transduction pathway on posttranscriptional regulation,
diﬀerences between transcription and translation, induction
of antioxidant enzyme activity/synthesis, and variation in
the cellular redox status [32, 61–67]. Our results also
corroborate previous ﬁndings which showed that Nrf2 plays
a more important transcriptional role in the expression of
GST than other ROS-scavenging enzymes [53, 54]. This
study also showed that elevated blood pressure is associated
with increased oxidative damage and downregulated mRNA
expressions of Nrf2 in kidney of SHR. Our data indicate
that the attenuation of antioxidant enzymes (and/or perhaps
scavenging of H2O2/ROS) as a result of honey supple-
mentation may contribute to the moderately upregulated
expression of Nrf2 in the kidney of SHR. The reduction
of elevated blood pressure, protection of kidney against
oxidative damage, and the attenuation of GST and CAT
activities as a result of honey supplementation corroborate
the beneﬁcial eﬀects of tualang honey on hypertension and
oxidative stress in SHR.
4.MaterialsandMethods
4.1. Materials
4.1.1. Chemicals. Thiobarbituric acid (TBA), GSH, and
GSSG were purchased from Sigma-Aldrich (St. Louis, MO,
USA).GSH:GSSGassaykitwaspurchasedfromCalbiochem
(CA, USA). SOD and GPx assay kits were purchased from
Cayman(MI,USA).Bio-Radproteinassaykitwaspurchased
from Bio-Rad (USA). RNA Later solution and RNeasy Mini
Kit were purchased from Qiagen (Hilden, Germany). cDNA
synthesis kit was purchased from Bioline (Randolph, USA).
The primers were purchased from 1st Base (Singapore).
FastStart Universal SYBR Green Master (Rox) was purchased
from Roche Dignostics (IN, USA). All other chemicals used
were of analytical grade obtained from commercial sources.
4.1.2. Animals. All experimental protocols were approved by
the Animal Ethics Committee of Universiti Sains Malaysia,
Malaysia [USM/Animal Ethics Approval/2009/(46) (145)].
Male spontaneously hypertensive (SHR) and Wistar-Kyoto
(WKY) rats, 12–14 weeks old, were obtained from the Lab-
oratory Animal Research Unit of Universiti Sains Malaysia,
Health Campus, Kelantan, Malaysia. The rats were accli-
matized to the animal room conditions for at least one
week prior to the experiment. Handling of animals was in
compliance with the Institutional Guidelines for the Care
andUseofAnimalsforScientiﬁcPurposes.Theanimalswere
cagedindividuallyinpolypropylenecagesinawell-ventilated
animal room with a 12-h dark/12h-light cycle (lights on
7.00 a.m., lights oﬀ 7.00 p.m.) and controlled temperature
(25 ± 2◦C). All the rats had free access to standard diet and
drinking water ad libitum.
4.1.3. Tualang Honey. Tualang honey (AgroMas, Malaysia)
was supplied by Federal Agricultural Marketing Authority
(FAMA),Kedah,Malaysia.Thehoneyhasthefollowingcom-
position: total reducing sugar (67.5%) [fructose (29.6%),
glucose (30.0%), maltose (7.9%), fructose/glucose ratio
(0.99)], sucrose (0.6%), and water (20.0%). The honey was
diluted with distilled water (1:1) before it was administered.
The dose (1.0g/kg) was chosen based on our previous study
[21].
4.2. Methods
4.2.1. Treatment. The WKY and SHR rats were randomly di-
vided into four groups consisting of six to seven rats. The
animals were treated via oral gavage once daily for 12 weeks
as follows:
Group 1: WKY rats received distilled water (0.5mL).
Group 2: WKY rats received tualang honey (1.0g/kg
body weight).
Group 3: SHR were administered distilled water
(0.5mL).
Group 4: SHR were administered tualang honey
(1.0g/kg body weight).
4.2.2. Measurement of Systolic Blood Pressure (SBP). SBP was
measured in conscious rats by a tail-cuﬀ plethysmographic
noninvasive method (Model 179, Life Science, USA) every
two weeks as previously described [12]. Brieﬂy, conscious
rats were placed on a heated pad in a temperature-controlled
space. They were allowed to calm for about 15 minutes
with the tail placed inside a tail cuﬀ.T h ec u ﬀ was inﬂated
and released several times to condition the animal to the
procedure. Four consecutive measurements were then taken
by a rat-tail blood pressure monitor, recorded by a student
oscillograph (Harvard Apparatus Inc., MA, USA). Each SBP
was obtained by averaging 4 individual readings.
4.2.3. Processing of Tissues. After 12 weeks of treatment, the
animals were sacriﬁced. The left kidney was rapidly excised,
washed in ice-cold phosphate-buﬀered saline, blotted and
immediately stored at −80◦C until processing. The frozen
left kidney was allowed to thaw on ice. Homogenates (10%
w/v) were prepared in Tris-HCl (0.1M, pH 7.4) with the aid
of a tissue grinder ﬁtted with a motor-driven ground glass
pestle (Glas-Col, USA) at 900 revolution per minute (rpm).
Homogenates were centrifuged at 1000×gf o r1 0m i n u t e s
at 4◦C in a refrigerated centrifuge to remove tissue debris
without precipitation of plasma membrane fragments. The
resulting supernatant was used for the assay of total protein,
activities of antioxidant enzymes, and markers of oxidative
stress.
4.2.4. Lipid Peroxidation (LPO) Assay. LPO was determined
as the concentration of MDA according to the method of
Ohkawa et al. [68]. Brieﬂy, 100μL of kidney homogenates
(10% w/v) or MDA standards were pipetted into test tubes
containing 1.5mL of 20% (v/v) glacial acetic acid (pH 3.5),
200μLof8.1%(w/v)sodiumdodecylsulphate(SDS),1.5mL
of 0.8% (w/v) TBA, and 700μL of distilled water. The test
tubes were incubated at 95◦C for 60 minutes with a marble
on top of each test tube. After incubation, the test tubes were
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amount of MDA formed was measured spectrophotometri-
callyat532nm.1,1,3,3-Tetraethoxypropane(TEP),aformof
MDA,wasusedasstandardinthisassay.MDAconcentration
was expressed as nmol of MDA per mg protein.
4.2.5. Reduced, Oxidized, and Total Glutathione Assays. Total
glutathione and GSSG were estimated using GSH:GSSG
ratioassaykit(Calbiochem,CA,USA)accordingtotheman-
ufacturer’s instructions. GSH was then calculated. Brieﬂy,
the kidney homogenates (10% w/v) were deproteinized
in metaphosphoric acid (5% w/v), centrifuged, and the
supernatants were used for the estimation of glutathione.
For GSSG assay, the kidney homogenates were immedi-
ately mixed with the thiol-scavenging reagent, 1-methy-
2-vinylpyridinium triﬂuoromethanesulfonate to derivatize
GSH. Samples were mixed sequentially with the chromogen
5,5 -dithiobis-2-nitrobenzoic acid, glutathione reductase,
a n dN A D P H .T h ea b s o r b a n c eo fe a c hs a m p l ew a sr e c o r d e d
at 412nm, and the reaction rate was determined. A
standard curve was constructed using a known quantity
of GSH standards. GSH and GSSG concentrations were
calculated by linear regression against the standard curve.
GSH/GSSG ratio was calculated using the formula [ratio =
(GSH − 2GSSG)/GSSG]. GSH and GSSG concentrations
were expressed as nM of glutathione per mg protein.
4.2.6. Total Antioxidant Status (TAS) Assay. TAS was mea-
sured according to the method of Koracevic et al. [69].
Brieﬂy, 10μL of kidney homogenate (10% w/v) was pipetted
in a test tube containing 0.49mL of 100mM sodium
phosphate buﬀer (100mM). This was followed by the
addition of 0.5mL of 10mM sodium benzoate (10mM)
solution, 0.2mL of Fe-EDTA mixture prepared from 2mM
EDTA solution and 2mM Fe(NH4)2(SO4)2 solution, and
0.2mL of H2O2 (10mM) solution. Each sample had its
own control (blank) in which 1mL of acetic acid (20%)
was added followed by the addition of 0.2mL of Fe-EDTA
mixture and 0.2mL of H2O2 (10mM). Negative control
(with phosphate buﬀer instead of the kidney homogenate)
containing similar reagents as in sample test tubes was
also prepared. After the addition of these reagents, the
test tubes were vortexed and incubated at 37◦Cf o r6 0
minutes. This was followed by the addition of 1mL of
acetic acid (20%) (sample test tubes only) and TBA (0.8%
w/v). The reaction tubes were incubated at 100◦Cf o r1 0
minutes. After cooling to room temperature, the absorbance
of the mixture was measured spectrophotometrically at
532nm against distilled water. TAS levels in the kidney
homogenates were calculated using uric acid as standard.
T A Sw a se x p r e s s e da sn m o lu r i ca c i de q u i v a l e n tp e rm g
protein.
4.2.7. Superoxide Dismutase (SOD) Assay. SOD activity was
measured using Cayman (MI, USA) assay kit according
to the manufacturer’s instructions. This assay kit utilizes
a tetrazolium salt for the detection of superoxide radicals
generated by xanthine oxidase and hypoxanthine. One
unit of SOD is deﬁned as the amount of enzyme needed
to exhibit 50% dismutation of O2
•−. The SOD assay
measures all the three types of SOD (Cu/Zn, Mn, and
FeSOD).
4.2.8. Glutathione Peroxidase (GPx) Assay. GPx activity was
measured using Cayman (MI, USA) assay kit according to
manufacturers’ instructions. This kit measures GPx activity
indirectly by a coupled reaction with GR. GSSG, produced
upon the reduction of hydroperoxide by GPx, is recycled
to its reduced state by GR and NADPH. The oxidation of
NADPH is accompanied by a decrease in absorbance at
340nm. One unit of GPx is deﬁned as the amount of enzyme
that catalyzes the oxidation of 1nmol of NADPH per minute
at 25◦C.
4.2.9. Catalase (CAT) Assay. CAT activity was measured
according to the method of Goth [70]. Brieﬂy, this assay
involves the incubation of sample test tube containing
0.5mL of hydrogen peroxide (65mM) and 0.1mL of kidney
homogenate (10% w/v). After incubation at 37◦Cf o r6 0
seconds, the enzymatic reaction was stopped by the addition
of0.5mLofammoniummolybdate(32.4mM)solution.The
yellow complex of ammonium molybdate and hydrogen per-
oxide was then measured spectrophotometrically at 405nm.
One unit of CAT is deﬁned as the amount of enzyme that
catalyzes the decomposition of 1μmol of hydrogen peroxide
per minute.
4.2.10. Glutathione Reductase (GR) Assay. GR activity was
assayed according to the method of Goldberg and Spooner
[71]. Brieﬂy, 1mL of 2.728mM GSSG solution and 40μL
of kidney homogenate (10% w/v) were incubated for 5
minutes at 37◦C. After incubation, the reaction was initiated
by the addition of 200μL of 1.054mM NADPH solution.
The decrease in absorbance was measured at 340nm using
spectrophotometer and recorded every 30 seconds over a
period of 5 minutes. GR activity was expressed as unit per
mg protein based on molar extinction coeﬃcient of 6.22 ×
103 L/mol/cm. One unit of GR is deﬁned as the amount of
enzymethatcatalyzestheoxidationof1nmolofNADPHper
minute.
4.2.11. Glutathione-S-Transferase (GST) Assay. GST activity
was assayed according to the method of Habig et al. [72].
Brieﬂy,2mLof0.3Mpotassium phosphate buﬀer(pH 6.35),
75μL of 30mM CDNB solution, 725μL of distilled water,
and 0.1mL of kidney homogenate (10% w/v) were pipetted
into a test tube. The test tube was vortexed and incubated
at 37◦C for 10 minutes. After incubation, the reaction was
initiated by the addition of 100μLo f3 0m M - r e d u c e dg l u -
tathione solution. The decrease in absorbance was measured
spectrophotometrically at 340nm and recorded every 30
seconds for 4 minutes. GST activity was calculated as unit
per mg protein based on a molar extinction coeﬃcient of
9.6×103 L/mol/cm.OneunitofGSTisdeﬁnedastheamount
of enzyme that catalyzes the conjugation of 1nmol of GSH-
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Table 3: Gene-speciﬁc primers for all the genes investigated.
Gene Genbank accession no Primer sequence PCR product (bp) Annealing temp. (◦C)
CuZnSOD NM017050 F: 5 -GCAGAAGGCAAGCGGTGAAC-3 
447 62
R: 5 -TAGCAGGACAGCAGATGAGT-3 
MnSOD NM017051 F: 5 -CTGAGGAGAGCAGCGGTCGT-3 
258 68
R: 5 -CTTGGCCAGCGCCTCGTGGT-3 
CAT BC081853 F: 5 -GCGAATGGAGAGGCAGTGTAC-3 
652 67
R: 5 -GAGTGACGTTGTCTTCATTAGCACTG-3 
GPx1 M21210 F: 5 -CTCTCCGCGGTGGCACAGT-3 
290 57
R: 5 -CCACCACCGGGTCGGACATAC-3 
GST-π L29427 F: 5 -GGAGGAGGTGGTTACCATAGATGTC-3 
389 68
R: 5 -GCAGGTCCAGCAAGTTGTAATCTGC-3 
GST-α 1/2 AF111160 F: 5 -CCACCTGCTGGAACTTCTCCTCTAT-3 
99 68
R: 5 -AGGCTGCTGATTCTGCTCTTGAAGG-3 
Nrf2 NM031789 F: 5 -CCATTTACGGAGACCCAC-3 
448 55
R: 5 -TGAGCGGCAACTTTATTC-3 
β-actin NM031144 F: 5 -CTGACCGAGCGTGGCTAC-3 
505 58
R: 5 -CCTGCTTGCTGATCCACA-3 
4.2.12. Protein Assay. Protein concentration was estimated
using Bio-Rad protein assay kit based on the method of
Bradford [73]. A standard curve was generated using bovine
serum albumin as standard.
4.2.13. Real-Time Reverse Transcription-Polymerase Chain
Reaction (RT-PCR) Assay. The excised kidneys were stored
in RNA Later solution (Qiagen, Hilden, Germany) overnight
at 4◦Cb e f o r et r a n s f e r r e dt o−80◦C until the isolation
of RNA. Total RNA was isolated using RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. RNA was eluted in 40μL of RNase-free water.
The concentration of isolated RNA was quantiﬁed at 260nm
using Inﬁnite 200 NanoQuant (Tecan, USA). The ratio of the
readings of absorbance at 260nm and 280nm (A260/A280),
ranging from 1.95 to 2.10, was used as an estimate of the
purity of isolated RNA. The integrity of extracted RNA
was checked by 1% agarose gel electrophoresis stained with
ethidium bromide. Single-strand cDNA was synthesized
using cDNA synthesis kit (Bioline, Randolph, USA) accord-
ing to the manufacturer’s instructions. Brieﬂy, single-strand
cDNA synthesis was carried out by incubating a PCR tube
containing 1μg of the isolated RNA, 1uL of oligo (dT)18,
and 10mM of dNTP at 65◦Cf o r1 0m i n u t e s .T h et u b ew a s
chilled on ice for 2 minutes. 4uL of 5x RT buﬀer, 1uL of
RNase inhibitor, 0.25uL of reverse transcriptase, and 4.75uL
of DEPC-treated water were added to the primed RNA. The
reaction mixture was incubated at 37◦Cf o r1 5m i n u t e s ,
followed by incubation at 42◦C for another 15 minutes, and
ﬁnally incubated at 45◦Cf o r3 0m i n u t e s .T h er e a c t i o nw a s
terminated by incubating at 70◦C for 15 minutes followed by
cooling on ice.
A number of tests were performed in order to ensure
that the primers were speciﬁc and eﬃcient. Diﬀerent con-
centrations of primers were analyzed by performing positive
and negative control PCR at several annealing temperatures,
ranging from 54◦Ct o6 8 ◦C. The PCR product was subjected
to 1.5% agarose gel electrophoresis to detect primer speci-
ﬁcity by revealing the presence or absence of primer dimers.
The reverse transcription polymerase chain reaction (RT-
PCR) quantiﬁcation was performed using Mx3000P real-
time PCR instrument (Stratagene, TX, USA). Each PCR
reaction contained 2μL of cDNA, 12.5μLo f2× FastStart
Universal SYBR Green Master (Rox) (Roche Dignostics,
IN, USA), 0.5μL of 300nM of the forward, and reverse
primers and 14.5μLo fP C R - g r a d ew a t e r .F o re a c hs e to f
primers, a control PCR mixture without template cDNA
was subjected to PCR in parallel to exclude potential DNA
carry-over during sample preparation. The reactions were
performed on a 96-well plate, and a PCR ampliﬁcation
protocol was followed. Ampliﬁcation was performed for
35 cycles of denaturation at 95◦C for 1 minute, annealing
at 55◦C–68◦C (speciﬁc for each gene) for 1 minute, and
extension at 72◦C for 1 minute, followed by a melting curve
phase. Prior to the melting curve phase, the PCR reaction
mixture was incubated at 95◦C for 1min and then ramped
down to 55◦C for 30sec. The melting curve analysis was
then carried out by increasing the temperature from 55◦C
to 95◦C which occurred at the instrument default rate of
0.2◦C/sec. The instrument then collected the ﬂuorescence
data on the 55–95◦C ramp persistently for about 15 minutes.
The postampliﬁcation melting curve was to conﬁrm the
presence of a single PCR product. The quality of the PCR
product was analyzed by 1.5% agarose gel electrophoresis.
Primer sequences used in the RT-PCR experiments were
based on the published sequences and synthesized by First
Base (Singapore) according to the cDNA sequences obtained
from the GenBankTM database for rat. The quantitation
of the each target gene in all the samples was normalized
to β-actin expression. The primer sequences for β-actin
(as a housekeeping gene), CuZnSOD, CAT and GPx [74],
MnSOD [75], GST-α [76], GST-Π [77], and Nrf2 [78]a r e
shown in Table 3. Fold changes in target gene expression
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of 2−ΔΔCT method, serial dilutions of cDNA were performed
to validate the ampliﬁcation eﬃciencies of each target gene
and housekeeping gene. The mean CT was calculated for the
target gene and housekeeping gene. The diﬀerence between
the CT target gene and CT β-actin was used as ΔCT.T h e
normotensive WKY control group served as the calibrator.
The mRNA expression levels of each group of rats were
presented as fold changes relative to the mRNA expression
levels of the WKY control rats.
4.2.14. Statistical Analysis. Statistical analysis wascarried out
using SPSS 18.0.1. Data were analyzed using independent
sample t-test to identify signiﬁcance of diﬀerence between
WKY and SHR. Repeated measures ANOVA was used to
analyzeandcomparesystolicbloodpressureandbodyweight
over the time course. Data are expressed as mean ± SEM. For
the analysis of antioxidant enzyme activities and oxidative
stress markers, each group consisted of six to seven rats. For
the analysis of mRNA expressions of antioxidant enzymes
and Nrf2, each group consisted of four to ﬁve rats.
5. Conclusions
These results indicate that cells or tissues may augment
components of the antioxidant defense system in order to
increasecellularresistanceandprotectagainstthedeleterious
eﬀects of oxidative stress. However, this adaptive response
may not always be protective against oxidative damage.
Findings from this study also indicate that expression of
Nrf2, a potential renoprotective transcription factor, is
markedlyreducedorimpaired inthekidney ofSHR.Besides,
our results reveal that the induction of antioxidant enzymes,
perhaps as a compensatory mechanism, may occur in spite
of impaired or reduced mRNA expression of Nrf2. The
administrationofhoneyprotectsthekidneyagainstoxidative
damage and attenuates oxidative stress-induced antioxidant
defenses in SHR. These honey-treated SHR also exhibit
reduced SBP. In conclusion, honey supplementation elicits
antihypertensive eﬀect via amelioration of oxidative stress
in kidney of SHR. Additional studies in the future may
help to establish a linkage of hypertension to downregulated
activity and expression of Nrf2 or vice versa in SHR and/or
human hypertension. With our results, we anticipate a
renewed interest in studies that investigate how and to what
extent this transcription factor; Nrf2 may interact with other
mechanisms to cause or exacerbate hypertension.
Acknowledgments
This work was supported by a Grant (1001/PPSP/81202020)
from Universiti Sains Malaysia (USM). The ﬁrst author is
thankful to USM for the award of Fellowship. We acknowl-
edge Dr. Teguh Haryo Sasongko, Ms. Fatemeh Hayati, Mr.
Ariﬁn Harun, and Mr. Koh Chun Haw for their assistance
in the laboratory procedures. We also express our appreci-
ation to Federal Agricultural Marketing Authority (FAMA),
Kedah, Malaysia for providing tualang honey.
References
[1] N. Poulter and Ritchie, “Global risk of cardiovascular disease,”
Heart, vol. 89, no. 2, pp. 2–5, 2003.
[2] World Health Organization, The World Health Report 2002.
Reducing Risks, Promoting Healthy Life,W H O ,G e n e v a ,
Switzerland, 2002.
[3] P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K.
Whelton, and J. He, “Global burden of hypertension: analysis
of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–
223, 2005.
[4] A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Sev-
enth report of the joint national committee on prevention,
detection, evaluation, and treatment of high blood pressure,”
Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003.
[ 5 ] R .R o d r i g o ,J .G o n z´ alez, and F. Paoletto, “The role of oxidative
stress in the pathophysiology of hypertension,” Hypertension
Research, vol. 34, no. 4, pp. 431–440, 2011.
[6] V. Ostrow, S. Wu, A. Aguilar, R. Bonner, E. Suarez, and F.
De Luca, “Association between oxidative stress and masked
hypertension in a multi-ethnic population of obese children
and adolescents,” Journal of Pediatrics, vol. 158, pp. 628–633,
2010.
[7] Y. Hirooka, “Oxidative stress in the cardiovascular center has
a pivotal role in the sympathetic activation in hypertension,”
Hypertension Research, vol. 34, no. 4, pp. 407–412, 2011.
[8] C. Fanelli and R. Zatz, “Linking oxidative stress, the renin-
angiotensin system, and hypertension,” Hypertension, vol. 57,
no. 3, pp. 373–374, 2011.
[9] A. A. Banday and M. F. Lokhandwala, “Oxidative stress
causes renal angiotensin II Type 1 receptor upregulation,
Na+/H+ exchanger 3 overstimulation, and hypertension,”
Hypertension, vol. 57, no. 3, pp. 452–459, 2011.
[10] S. Shull, N. H. Heintz, M. Periasamy et al., “Diﬀerential reg-
ulation of antioxidant enzymes in response to oxidants,” The
Journal of Biological Chemistry, vol. 266, no. 36, pp. 24398–
24403, 1991.
[11] E. R¨ ohrdanz and R. Kahl, “Alterations of antioxidant enzyme
expression in response to hydrogen peroxide,” Free Radical
Biology and Medicine, vol. 24, no. 1, pp. 27–38, 1998.
[12] O. O. Erejuwa, S. A. Sulaiman, M. S. A. Wahab, K. N.
S .S i r a j u d e e n ,M .S .M .S a l l e h ,a n dS .G u r t u ,“ D i ﬀerential
responses to blood pressure and oxidative stress in strepto-
zotocin-induced diabetic wistar-kyoto rats and spontaneously
hypertensive rats: eﬀects of antioxidant (Honey) treatment,”
International Journal of Molecular Sciences,v o l .1 2 ,n o .3 ,p p .
1888–1907, 2011.
[13] M. C. Houston, “The role of cellular micronutrient analysis,
nutraceuticals, vitamins, antioxidants and minerals in the
prevention and treatment of hypertension and cardiovascular
disease,” Therapeutic Advances in Cardiovascular Disease, vol.
4, no. 3, pp. 165–183, 2010.
[14] T. J. Kizhakekuttu and M. E. Widlansky, “Natural antioxidants
and hypertension: promise and challenges,” Cardiovascular
Therapeutics, vol. 28, no. 4, pp. e20–e32, 2010.
[15] S. Bogdanov, T. Jurendic, R. Sieber, and P. Gallmann, “Honey
for nutrition and health: a review,” J o u r n a lo ft h eA m e r i c a n
College of Nutrition, vol. 27, no. 6, pp. 677–689, 2008.
[16] H. T. Tan, R. A. Rahman, S. H. Gan et al., “The antibacterial
properties of Malaysian tualang honey against wound and
enteric microorganisms in comparison to manuka honey,”
BMC Complementary and Alternative Medicine, vol. 9, article
34, 2009.12 Oxidative Medicine and Cellular Longevity
[17] A. A. Ghashm, N. H. Othman, M. N. Khattak, N. M. Ismail,
and R. Saini, “Antiproliferative eﬀect of Tualang honey on oral
squamous cell carcinoma and osteosarcoma cell lines,” BMC
Complementary and Alternative Medicine, vol. 10, article 49,
2010.
[18] X. H. Wang, L. Andrae, and N. J. Engeseth, “Antimutagenic
eﬀect of various honeys and sugars against Trp-p-1,” Journal
of Agricultural and Food Chemistry, vol. 50, no. 23, pp. 6923–
6928, 2002.
[19] N. S. Al-Waili, K. Y. Saloom, T. N. Al-Waili et al., “Inﬂuence
of various diet regimens on deterioration of hepatic function
and hematological parameters following carbon tetrachloride:
a potential protective role of natural honey,” Natural Product
Research, vol. 20, no. 13, pp. 1258–1264, 2006.
[20] O. O. Erejuwa, S. A. Sulaiman, M. S. Wahab, K. N. S.
S i r a j u d e e n ,M .S .M .D .S a l l e h ,a n dS .G u r t u ,“ A n t i o x i -
dant protection of Malaysian tualang honey in pancreas of
normal and streptozotocin-induced diabetic rats,” Annales
d’Endocrinologie, vol. 71, no. 4, pp. 291–296, 2010.
[21] O. O. Erejuwa, S. Gurtu, S. A. Sulaiman, M. S. A. Wahab, K. N.
S.Sirajudeen,andM.S.M.Salleh,“Hypoglycemicandantiox-
idant eﬀects of honey supplementation in streptozotocin-
induced diabetic rats,” International Journal for Vitamin and
Nutrition Research, vol. 80, no. 1, pp. 74–82, 2010.
[22] R. L. Rodgers, “Depressor eﬀect of diabetes in the sponta-
neously hypertensive rat: associated changes in heart perfor-
mance,” Canadian Journal of Physiology and Pharmacology,
vol. 64, no. 9, pp. 1177–1184, 1986.
[23] D. Susic, A. K. Mandal, D. J. Jovovic, G. Radujkovic, and
D. Kentera, “Streptozotocin-induced diabetes mellitus lowers
blood pressure in spontaneously hypertensive rat,” Clinical
and Experimental Hypertension—Part A,v o l .1 2 ,n o .6 ,p p .
1021–1035, 1990.
[24] A. J. Davidoﬀ, F. M. Pinault, and R. L. Rodgers, “Ventricular
relaxation of diabetic spontaneously hypertensive rat,” Hyper-
tension, vol. 15, no. 6, pp. 643–651, 1990.
[25] R. M. Touyz and E. L. Schiﬀrin, “Reactive oxygen species in
vascular biology: implications in hypertension,” Histochem-
istry and Cell Biology, vol. 122, no. 4, pp. 339–352, 2004.
[26] J. Z. Xu, Y. Zhang, S. N. Wu, W. Q. Niu, D. L. Zhu, and P. J.
Gao, “Impaired endothelial function in hypertensive patients
with target organ damage,” J o u r n a lo fH u m a nH y p e r t e n s i o n ,
vol. 23, no. 11, pp. 751–757, 2009.
[27] C. Tsiouﬁs, A. Kordalis, D. Flessas et al., “Pathophysiology
of resistant hypertension: the role of sympathetic nervous
system,” International Journal of Hypertension, vol. 2011,
Article ID 642416, 7 pages, 2011.
[28] H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama,
“The intrarenal renin-angiotensin system: from physiology
to the pathobiology of hypertension and kidney disease,”
Pharmacological Reviews, vol. 59, no. 3, pp. 251–287, 2007.
[29] F. A. Delano and G. W. Schmid-Sch¨ onbein, “Proteinase activ-
ity and receptor cleavage: mechanism for insulin resistance in
the spontaneously hypertensive rat,” Hypertension, vol. 52, no.
2, pp. 415–423, 2008.
[30] J. R. Sowers, “Insulin resistance and hypertension,” American
J o u r n a lo fP h y s i o l o gy , vol. 286, no. 5, pp. H1597–H1602, 2004.
[31] I. Fridovich, “Superoxide anion radical (O2/-·), superoxide
dismutases, and related matters,” The Journal of Biological
Chemistry, vol. 272, no. 30, pp. 18515–18517, 1997.
[32] F. Haber and J. Weiss, “The catalytic decomposition of hydro-
genperoxidebyironsalts,”ProceedingsoftheRoyalSociety,vol.
147, pp. 332–351, 1934.
[33] M. Tiedge, S. Lortz, R. Munday, and S. Lenzen, “Protection
against the co-operative toxicity of nitric oxide and oxygen
free radicals by overexpression of antioxidant enzymes in
bioengineeredinsulin-producingRINm5Fcells,”Diabetologia,
vol. 42, no. 7, pp. 849–855, 1999.
[34] D. R. Crawford and K. J. A. Davies, “Adaptive response and
oxidative stress,” Environmental Health Perspectives, vol. 102,
no. 10, pp. 25–28, 1994.
[35] G. F. Gaetani, S. Galiano, L. Canepa, A. M. Ferraris, and
H. N. Kirkman, “Catalase and glutathione peroxidase are
equallyactiveindetoxiﬁcationofhydrogenperoxideinhuman
erythrocytes,” Blood, vol. 73, no. 1, pp. 334–339, 1989.
[36] Z. Spolarics and J. X. I. Wu, “Role of glutathione and catalase
in H2O2 detoxiﬁcation in LPS- activated hepatic endothelial
andKupﬀercells,”AmericanJournalofPhysiology,vol.273,no.
6, pp. G1304–G1311, 1997.
[37] P. Cao, O. Ito, Q. Guo et al., “Endogenous hydrogen peroxide
up-regulates the expression of nitric oxide synthase in the
kidney of SHR,” Journal of Hypertension,v o l .2 9 ,n o .6 ,p p .
1167–1174, 2011.
[38] S.BhanjaandG.B.N.Chainy,“PTU-inducedhypothyroidism
modulates antioxidant defence status in the developing cere-
bellum,” International Journal of Developmental Neuroscience,
vol. 28, no. 3, pp. 251–262, 2010.
[39] H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry
and Biochemistry of 4-hydroxynonenal, malonaldehyde and
related aldehydes,” Free Radical Biology and Medicine, vol. 11,
no. 1, pp. 81–128, 1991.
[40] J. W. Phillis, “A “radical” view of cerebral ischemic injury,”
Progress in Neurobiology, vol. 42, no. 4, pp. 441–448, 1994.
[41] X. Hou, Y. H. Shen, C. Li et al., “PPARα agonist fenoﬁbrate
protects the kidney from hypertensive injury in spontaneously
hypertensive rats via inhibition of oxidative stress and MAPK
activity,” Biochemical and Biophysical Research Communica-
tions, vol. 394, no. 3, pp. 653–659, 2010.
[42] J. Red´ on, M. R. Oliva, C. Tormos et al., “Antioxidant activities
and oxidative stress byproducts in human hypertension,”
Hypertension, vol. 41, no. 5, pp. 1096–1101, 2003.
[43] R. Sharma, Y. Yang, A. Sharma, S. Awasthi, and Y. C. Awasthi,
“Antioxidant role of glutathione S-transferases: protection
against oxidant toxicity and regulation of stress-mediated
apoptosis,” Antioxidants and Redox Signaling,v o l .6 ,n o .2 ,p p .
289–300, 2004.
[44] J. D. Hayes and R. C. Strange, “Potential contribution of the
glutathione S-transferase supergene family to resistance to
oxidative stress,” Free Radical Research, vol. 22, no. 3, pp. 193–
207, 1995.
[45] B. Mannervik, “The isoenzymes of glutathione transferase,”
Advances in Enzymology and Related Areas of Molecular
Biology, vol. 57, pp. 357–417, 1985.
[ 4 6 ]M .D e r b e l ,T .I g a r a s h i ,a n dT .S a t o h ,“ D i ﬀerential induction
of glutathione S-transferase subunits by phenobarbital, 3-
methylcholanthrene and ethoxyquin in rat liver and kidney,”
Biochimica et Biophysica Acta, vol. 1158, no. 2, pp. 175–180,
1993.
[47] R. Pinkus, L. M. Weiner, and V. Daniel, “Role of oxidants
and antioxidants in the induction of AP-1, NF-κB, and
glutathione S-transferase gene expression,” The Journal of
Biological Chemistry, vol. 271, no. 23, pp. 13422–13429, 1996.
[ 4 8 ]J .H u a n g ,P .H .T a n ,B .K .T a n ,a n dB .H .B a y ,“ G S T - p i
expression correlates with oxidative stress and apoptosis in
breast cancer,” Oncology Reports, vol. 12, no. 4, pp. 921–925,
2004.Oxidative Medicine and Cellular Longevity 13
[49] J. R. Koo, K. H. Liang, and N. D. Vaziri, “Microarray analysis
of altered gene expression in kidneys of adult spontaneously
hypertensive rats,” Journal of Applied Research, vol. 4, no. 1,
pp. 111–126, 2004.
[50] H. J. Kim and N. D. Vaziri, “Contribution of impaired
Nrf2-Keap1 pathway to oxidative stress and inﬂammation in
chronic renal failure,” American Journal of Physiology, vol. 298,
no. 3, pp. F662–F671, 2010.
[51] H. Motohashi and M. Yamamoto, “Nrf2-Keap1 deﬁnes a
physiologically important stress response mechanism,” Trends
in Molecular Medicine, vol. 10, no. 11, pp. 549–557, 2004.
[52] M. Kobayashi, L. Li, N. Iwamoto et al., “The antioxidant
defense system Keap1-Nrf2 comprises a multiple sensing
mechanism for responding to a wide range of chemical
compounds,”Molecular and CellularBiology, vol. 29,no. 2,pp.
493–502, 2009.
[53] S. A. Chanas, Q. Jiang, M. McMahon et al., “Loss of the Nrf2
transcription factor causes a marked reduction in constitutive
and inducible expression of the glutathione S-transferase
Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the
livers of male and female mice,” Biochemical Journal, vol. 365,
no. 2, pp. 405–416, 2002.
[54] S. A. Reisman, R. L. Yeager, M. Yamamoto, and C. D. Klaassen,
“Increased Nrf2 activation in livers from keap1-knockdown
mice Increases expression of cytoprotective genes that detoxify
electrophiles more than those that detoxify reactive oxygen
species,”Toxicological Sciences,vol.108,no.1,pp.35–47,2009.
[55] J. L. Ning, L. W. Mo, and X. N. Lai, “Low-and high-dose
hydrogen peroxide regulation of transcription factor NF-E2-
related factor 2,” Chinese Medical Journal, vol. 123, no. 8, pp.
1063–1069, 2010.
[ 5 6 ]A .I .R o j o ,P .R a d a ,J .E g e a ,A .O .R o s a ,M .G .L ´ opez,
and A. Cuadrado, “Functional interference between glycogen
synthase kinase-3 beta and the transcription factor Nrf2 in
protection against kainate-induced hippocampal celldeath,”
Molecular and Cellular Neuroscience, vol. 39, no. 1, pp. 125–
132, 2008.
[57] O. O. Erejuwa, S. A. Sulaiman, M. S. ab Wahab, S. K.N.
Salam, M. S. md Salleh, and S. G. Gurtu, “Comparison of
antioxidant eﬀects of honey, glibenclamide, metformin, and
their combinations in the kidneys of streptozotocin-induced
diabetic rats,” International Journal of Molecular Sciences, vol.
12, no. 1, pp. 829–843, 2011.
[58] D. Binda, L. Nicod, C. Viollon-Abadie et al., “Strain diﬀerence
(WKY, SPRD) in the hepatic antioxidant status in rat and
eﬀect of hypertension (SHR, DOCA). Ex vivo and in vitro
data,” Molecular and Cellular Biochemistry, vol. 218, no. 1-2,
pp. 139–146, 2001.
[59] K. C. Kregel and H. J. Zhang, “An integrated view of oxidative
stress in aging: basic mechanisms, functional eﬀects, and
pathological considerations,” American Journal of Physiology,
vol. 292, no. 1, pp. R18–R36, 2007.
[60] P. Gomes, S. Sim˜ ao, E. Silva et al., “Aging increases oxida-
tive stress and renal expression of oxidant and antioxidant
enzymes that are associated with an increased trend in systolic
blood pressure,” Oxidative Medicine and Cellular Longevity,
vol. 2, no. 3, pp. 138–145, 2009.
[61] B.Ghosh,C.D.Hanevold,K.Dobashi,J.K.Orak,andI.Singh,
“Tissue diﬀerences in antioxidant enzyme gene expression in
responsetoendotoxin,”FreeRadicalBiologyandMedicine,vol.
21, no. 4, pp. 533–540, 1996.
[62] S. P. Gygi, Y. Rochon, B. R. Franza, and R. Aebersold,
“CorrelationbetweenproteinandmRNAabundanceinyeast,”
Molecular and Cellular Biology, vol. 19, no. 3, pp. 1720–1730,
1999.
[63] T. J. Griﬃn, S. P. Gygi, T. Ideker et al., “Complementary pro-
ﬁling of gene expression at the transcriptome and proteome
levels in Saccharomyces cerevisiae,” Molecular & Cellular
Proteomics, vol. 1, no. 4, pp. 323–333, 2002.
[64] D. Garc´ ıa-L´ opez, K. H¨ akkinen, M. J. Cuevas et al., “Eﬀects of
strength and endurance training on antioxidant enzyme gene
expression and activity in middle-aged men,” Scandinavian
Journal of Medicine and Science in Sports,v o l .1 7 ,n o .5 ,p p .
595–604, 2007.
[65] M. Arciello, C. R. Capo, S. D’Annibale et al., “Copper deple-
tionincreasesthemitochondrial-associatedSOD1inneuronal
cells,” BioMetals, vol. 24, no. 2, pp. 269–278, 2010.
[66] M.F.Tsan,J.E.White,C.Treanor,andJ.B.Shaﬀer,“Molecular
basisfortumornecrosisfactor-inducedincreaseinpulmonary
superoxide dismutase activities,” American Journal of Physiol-
ogy, vol. 259, no. 6, pp. L506–L512, 1990.
[67] L. B. Clerch and D. Massaro, “Tolerance of rats to hyperoxia.
Lung antioxidant enzyme gene expression,” The Journal of
Clinical Investigation, vol. 91, no. 2, pp. 499–508, 1993.
[68] H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides
in animal tissues by thiobarbituric acid reaction,” Analytical
Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
[69] D.Koracevic,G.Koracevic,V.Djordjevic,S.Andrejevic,andV.
Cosic,“Methodforthemeasurementofantioxidantactivityin
human ﬂuids,” Journal of Clinical Pathology, vol. 54, no. 5, pp.
356–361, 2001.
[70] L. Goth, “A simple method for determination of serum
catalase activity and revision of reference range,” Clinica
Chimica Acta, vol. 196, no. 2-3, pp. 143–151, 1991.
[71] D. M. Goldberg and R. J. Spooner, “Assay of glutathione
reductase,”inMethodsofEnzymaticAnalysis,H.V .Bergmeyen,
Ed., pp. 258–265, Chemie, Weinheim, Germany, 1983.
[72] W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione
S transferases. The ﬁrst enzymatic step in mercapturic acid
formation,” The Journal of Biological Chemistry, vol. 249, no.
22, pp. 7130–7139, 1974.
[73] M. M. Bradford, “A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein dye binding,” Analytical Biochemistry, vol.
72, no. 1-2, pp. 248–254, 1976.
[74] S. Chattopadhyay, D. K. Sahoo, U. Subudhi, and G. B.
N. Chainy, “Diﬀerential expression proﬁles of antioxidant
enzymes and glutathione redox status in hyperthyroid rats:
a temporal analysis,” Comparative Biochemistry and Physiolo-
gy—C, vol. 146, no. 3, pp. 383–391, 2007.
[75] S. W. Zangen, S. Ryu, and A. Ornoy, “Alterations in the
expression of antioxidant genes and the levels of transcription
factor NF-Kappa B in relation to diabetic embryopathy in the
cohen diabetic rat model,” Birth Defects Research Part A—
Clinical and Molecular Teratology, vol. 76, no. 2, pp. 107–114,
2006.
[76] G. Li, P. Xie, H. Li et al., “Acute eﬀects of microcystins on
the transcription of 14 glutathione S-transferase isoforms in
Wistar rat,” Environmental Toxicology, vol. 26, no. 2, pp. 187–
194, 2011.
[77] B. Bauer, A. M. S. Hartz, J. R. Lucking, X. Yang, G. M. Pollack,
and D. S. Miller, “Coordinated nuclear receptor regulation of
the eﬄux transporter, Mrp2, and the phase-II metabolizing
enzyme, GSTπ, at the blood-brain barrier,” Journal of Cerebral
Blood Flow and Metabolism, vol. 28, no. 6, pp. 1222–1234,
2008.14 Oxidative Medicine and Cellular Longevity
[78] H. Y. Li, S. Y. Wu, and N. Shi, “Transcription factor Nrf2
activationbydeltamethrininPC12cells:involvementofROS,”
Toxicology Letters, vol. 171, no. 1-2, pp. 87–98, 2007.
[79] K. J. Livak and T. D. Schmittgen, “Analysis of relative gene
expression data using real-time quantitative PCR and the 2-
ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.